Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
Voriconazole is an established first-line agent for treatment of invasive fungal infections in patients undergoing allogeneic stem cell transplantation (ASCT). It is associated with the uncommon complication of periostitis. We report this complication in a 58-year-old female undergoing HSCT. She was...
Saved in:
Main Authors: | Karen Sweiss, Annie Oh, Damiano Rondelli, Pritesh Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2016/3242196 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Voriconazole-induced periostitis in the hand
by: Gurbinder Singh, et al.
Published: (2025-03-01) -
Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
by: Amr Nassar, et al.
Published: (2014-01-01) -
Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
by: Vaibhav Agrawal, et al.
Published: (2020-01-01) -
Graft-Versus-Host Disease Sustains Coagulation Activity for two Years After Pediatric Allogeneic Hematopoietic Stem
Cell Transplantation
by: Satu Långström MD, PhD, et al.
Published: (2025-02-01) -
Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
by: Irene García Cadenas, et al.
Published: (2014-01-01)